T1	Participants 139 176	mother-to-child transmission of HIV-1
T2	Participants 564 596	pregnant women infected with HIV
T3	Participants 606 710	Pregnant women with WHO stage 1, 2, or 3 HIV-1 infection who had CD4 cell counts of 200-500 cells per Î¼L
T4	Participants 748 836	Burkina Faso, Kenya, and South Africa to start study treatment at 28-36 weeks' gestation
T5	Participants 1998 2055	From June, 2005, to August, 2008, 882 women were enrolled
